FR940721-2-00050 FR940721-2-00034 Advisory Committee Meeting; Amendment of Notice AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing an amendment to the notice of a meeting of the Nonprescription Drugs Advisory Committee, which is scheduled for July 27, 1994. This meeting was announced in the Federal Register of June 24, 1994 (59 FR 32699). The amendment is being made to reflect a change in the date of the meeting from a 1-day to a 2-day meeting and to announce a closed portion of the meeting, which is scheduled for the second day and which will be held at a location different from that of the open session. The open committee discussion remains the same as originally announced. This amendment will be announced at the beginning of the open portion of the meeting. FOR FURTHER INFORMATION CONTACT: Lee L. Zwanziger or Mae Brooks, Center for Drug Evaluation and Research (HFD&hyph;9), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301&hyph;443&hyph;4695. SUPPLEMENTARY INFORMATION: In the Federal Register of June 24, 1994, FDA announced that a meeting of the Nonprescription Drugs Advisory Committee would be held on June 27, 1994. On page 32699, in the third column, under ``Date, time, and place'' and ``Type of meeting and contact person,'' portions of this meeting are amended, and on page 32700, in the first column, because the committee will now have a closed portion on July 28, 1994, a ``Closed committee deliberations'' paragraph is added to read as follows: Date, time, and place. July 27, 1994, 2 p.m., Parklawn Bldg., conference rms. D and E, 5600 Fishers Lane, Rockville, MD, and July 28, 1994, 8:30 a.m., Montrose Room, Ramada Inn, 1775 Rockville Pike, Rockville, MD. Type of meeting and contact person. Open public hearing, July 27, 1994, 2 p.m. to 3 p.m., unless public participation does not last that long; open committee discussion, 3 p.m. to 6 p.m.; closed committee deliberations, July 28, 1994, 8:30 a.m. to 12 m.; Lee L. Zwanziger or Mae Brooks, Center for Drug Evaluation and Research (HFD&hyph;9), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301&hyph;443&hyph;4695. Closed committee deliberations. On July 28, 1994, the committee will discuss trade secret and/or confidential commercial information relevant to pending NDA's. This portion of the meeting will be closed to permit discussion of this information (5 U.S.C. 552b(c)(4)). Dated: July 14, 1994. Linda A. Suydam, Interim Deputy Commissioner for Operations. [FR Doc. 94&hyph;17695 Filed 7&hyph;20&hyph;94; 8:45 am] BILLING CODE 4160&hyph;01&hyph;F
